(Q51594153)

7 April 2018

title

Recombinant aprotinin in coronary artery bypass graft operations. (English)

1 reference

7 April 2018

coronary artery bypass surgery

main subject

1 reference

Green D

1

1 reference

7 April 2018

Sanders J

2

1 reference

7 April 2018

Eiken M

3

1 reference

7 April 2018

Wong CA

4

1 reference

7 April 2018

Frederiksen J

5

1 reference

7 April 2018

Joob A

6

1 reference

7 April 2018

Palmer A

7

1 reference

7 April 2018

Trowbridge A

8

1 reference

7 April 2018

Woodruff B

9

1 reference

7 April 2018

Moerch M

10

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 October 1995

1 reference

7 April 2018

The Journal of Thoracic and Cardiovascular Surgery

published in

1 reference

7 April 2018

volume

110

1 reference

7 April 2018

issue

4 Pt 1

1 reference

7 April 2018

page(s)

963-970

1 reference

7 April 2018

Effect of aprotinin on need for blood transfusion after repeat open-heart surgery

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980163-1

Low-dose aprotinin in internal mammary artery bypass operations contributes to important blood saving

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980163-1

Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980163-1

Disseminated intravascular coagulation after administration of aprotinin in combination with deep hypothermic circulatory arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980163-1

Identification of aprotinin degradation products by the use of high-performance capillary electrophoresis, high-pressure liquid chromatography and mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980163-1

Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980163-1

Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980163-1

Aprotinin in cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980163-1

Aprotinin prevents bleeding and has effects on platelets and fibrinolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980163-1

Platelet preservation during cardiopulmonary bypass with aprotinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980163-1

Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980163-1

IgE-mediated anaphylactic reaction to aprotinin during anaesthesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980163-1

10.1016/S0022-5223(05)80163-1

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018